PH30478A - Double-layered oxcarbazepine tablets - Google Patents

Double-layered oxcarbazepine tablets

Info

Publication number
PH30478A
PH30478A PH48839A PH48839A PH30478A PH 30478 A PH30478 A PH 30478A PH 48839 A PH48839 A PH 48839A PH 48839 A PH48839 A PH 48839A PH 30478 A PH30478 A PH 30478A
Authority
PH
Philippines
Prior art keywords
layered
double
oxcarbazepine
oxcarbazepine tablets
hydrophilic
Prior art date
Application number
PH48839A
Other languages
English (en)
Inventor
Bourquin Jacques
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of PH30478A publication Critical patent/PH30478A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH48839A 1993-09-08 1994-08-23 Double-layered oxcarbazepine tablets PH30478A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH267993 1993-09-08

Publications (1)

Publication Number Publication Date
PH30478A true PH30478A (en) 1997-05-28

Family

ID=4239144

Family Applications (1)

Application Number Title Priority Date Filing Date
PH48839A PH30478A (en) 1993-09-08 1994-08-23 Double-layered oxcarbazepine tablets

Country Status (14)

Country Link
US (2) US5472714A (fr)
EP (1) EP0646374B1 (fr)
JP (1) JP3636380B2 (fr)
KR (1) KR100319351B1 (fr)
AT (1) ATE164762T1 (fr)
AU (1) AU678492B2 (fr)
CA (1) CA2131495C (fr)
DE (1) DE59405627D1 (fr)
ES (1) ES2115188T3 (fr)
IL (1) IL110863A (fr)
NZ (1) NZ264407A (fr)
PH (1) PH30478A (fr)
SG (1) SG44498A1 (fr)
ZA (1) ZA946874B (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5472714A (en) * 1993-09-08 1995-12-05 Ciba-Geigy Corporation Double-layered oxcarbazepine tablets
SE9401738D0 (sv) * 1994-05-19 1994-05-19 Ewos Ab Bioactive feed
US6156340A (en) * 1996-03-29 2000-12-05 Duquesne University Of The Holy Ghost Orally administrable time release drug containing products
CO4920215A1 (es) * 1997-02-14 2000-05-29 Novartis Ag Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones
US20020022056A1 (en) * 1997-02-14 2002-02-21 Burkhard Schlutermann Oxacarbazepine film-coated tablets
KR19980077329A (ko) * 1997-04-18 1998-11-16 이범진 이중층 약물 함유 제어방출성 제제
GB9721497D0 (en) * 1997-10-09 1997-12-10 Ciba Geigy Ag Organic compounds
US7815937B2 (en) * 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
GB9925962D0 (en) * 1999-11-02 1999-12-29 Novartis Ag Organic compounds
GB9930058D0 (en) * 1999-12-20 2000-02-09 Novartis Ag Organic compounds
US6242003B1 (en) * 2000-04-13 2001-06-05 Novartis Ag Organic compounds
US20060127474A1 (en) * 2001-04-11 2006-06-15 Oskar Kalb Pharmaceutical compositions comprising fluvastatin
US20040197402A1 (en) * 2001-05-18 2004-10-07 Ashish Sehgal Oxcarbazepine dosage forms
CA2447881C (fr) * 2001-06-15 2014-02-11 Richard Eckhardt Procede et appareil pour steriliser ou desinfecter une region a travers un pansement
US7125563B2 (en) * 2002-04-12 2006-10-24 Dava Pharmaceuticals, Inc. Sustained release pharmaceutical preparations and methods for producing the same
AU2003240654A1 (en) * 2002-05-31 2003-12-19 Desitin Arzneimittel Gmbh Pharmaceutical composition containing oxcarbazepine and having a controlled active substance release
EP1528927A1 (fr) 2002-08-06 2005-05-11 Novartis AG Utilisation de carboxamides pour le traitement des acouphenes
GB0221956D0 (en) * 2002-09-20 2002-10-30 Novartis Ag Organic compounds
FR2846008B1 (fr) * 2002-10-18 2006-06-02 Centre Nat Rech Scient Criblage de molecules a activite anti-prion:kits, methodes et molecules criblees
FR2846009B1 (fr) * 2002-10-18 2007-10-12 Centre Nat Rech Scient Criblage de molecules a activite anti-prion:kits, methodes et molecules criblees
US20050208108A1 (en) * 2004-03-19 2005-09-22 Jannusch Leonard C Thermoplastic films and methods for making
PE20051156A1 (es) * 2004-03-22 2006-02-13 Novartis Ag Formulaciones de matriz orales que comprenden licarbazepina
WO2006046105A1 (fr) * 2004-10-25 2006-05-04 Ranbaxy Laboratories Limited Formes de dosage de l'oxcarbazepine
US20060111343A1 (en) * 2004-11-01 2006-05-25 Glenmark Pharmaceuticals Limited Oxcarbazepine dosage forms
WO2006070406A1 (fr) * 2004-12-29 2006-07-06 J.B. Chemicals & Pharmaceuticals Ltd Comprimés bicouches d'oxcarbazépine à libération contrôlée et procédé de préparation de ceux-ci
US20060252745A1 (en) 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
US20090143360A1 (en) * 2005-07-08 2009-06-04 Muhammed Safadi Oxcarbazepine Formulation
US9198862B2 (en) * 2005-07-22 2015-12-01 Rubicon Research Private Limited Dispersible tablet composition
US20070248684A1 (en) * 2006-01-31 2007-10-25 Sigal Blau Pharmaceutical formulations of oxcarbazepine and methods for its preparation
EP2029118A2 (fr) * 2006-01-31 2009-03-04 Teva Pharmaceutical Industries, Inc. Formulation pharmaceutique d'oxcarbazepine, et sa méthode de fabrication, caractérisée en ce que l'oxcarbazepine a une distribution de la taille des particules qui est large et multi-modale
AU2006337141A1 (en) * 2006-01-31 2007-08-09 Teva Pharmaceutical Industries Ltd. Oxcarbazepine pharmaceutical formulation and its method of preparation, wherein oxcarbazepine has a broad and multi-modal particle size distribution
ATE496623T1 (de) 2006-04-26 2011-02-15 Supernus Pharmaceuticals Inc Oxcarbazepin-zubereitungen für kontrollierte freisetzung mit sigmoidalem freisetzungsprofil
EP2018157A2 (fr) * 2006-04-26 2009-01-28 Astron Research Limited Formulation à libération à libération contrôlée comprenant des médicaments anti-épilepiques
US20080138403A1 (en) * 2006-12-08 2008-06-12 Sun Pharmaceutical Industries Ltd. Pharmaceutical dosage forms of oxcarbazepine
GB0700773D0 (en) 2007-01-15 2007-02-21 Portela & Ca Sa Drug therapies
CN103735527B (zh) * 2013-12-24 2014-09-10 武汉人福药业有限责任公司 一种奥卡西平片剂及其制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH500196A (de) * 1969-03-10 1970-12-15 Ciba Geigy Ag Verfahren zur Herstellung von neuen Azepinderivaten
CH605791A5 (fr) * 1974-09-27 1978-10-13 Ciba Geigy Ag
FI75561C (fi) * 1979-10-30 1988-07-11 Ciba Geigy Ag Foerfarande foer framstaellning av 5- karbamoyl-10-oxo-10,11-dihydro-5h-dibens/b,f/azepin och daertill noedvaendiga mellanprodukter.
US4543370A (en) * 1979-11-29 1985-09-24 Colorcon, Inc. Dry edible film coating composition, method and coating form
CH649080A5 (de) * 1981-04-16 1985-04-30 Ciba Geigy Ag 5h-dibenz(b,f)azepin-5-carboxamide als mittel zur prophylaxe und behandlung von zerebraler leistungsinsuffizienz.
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
JPS60105611A (ja) * 1983-11-14 1985-06-11 Nippon Chemiphar Co Ltd ニフエジピン軟カプセル剤
DE3541304A1 (de) * 1985-11-22 1987-05-27 Scherer Gmbh R P Orale zubereitungen von knoblauch und verfahren zu ihrer herstellung
US4906638A (en) * 1987-12-22 1990-03-06 Nova Pharmaceutical Corporation Dextromethorphan potentiator for anticonvulsant composition and method
US4931286A (en) * 1989-04-19 1990-06-05 Aqualon Company High gloss cellulose tablet coating
US5248516A (en) * 1989-12-19 1993-09-28 Fmc Corporation Film-forming composition: method of producing same and use for coating pharmaceuticals and foods and the like
US5198227A (en) * 1990-01-22 1993-03-30 Mcneil-Ppc, Inc. Dual subcoated simulated capsule medicament
HU206824B (en) * 1990-08-24 1993-01-28 Biogal Gyogyszergyar Process for the production of a table crystallizing in the monoclinic system, which contains light-, heat-, and moisture- sensitive active agents
US5326570A (en) * 1991-07-23 1994-07-05 Pharmavene, Inc. Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
US5231089A (en) * 1991-12-02 1993-07-27 University Of Florida Method of improving oral bioavailability of carbamazepine
US5411746A (en) * 1993-02-24 1995-05-02 Warner-Jenkinson Company, Inc. Dye compositions and methods for film coating tablets and the like
US5472714A (en) * 1993-09-08 1995-12-05 Ciba-Geigy Corporation Double-layered oxcarbazepine tablets
HU213407B (en) * 1993-12-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process for producing tablet with diffusive-osmotic release
JP4375686B2 (ja) * 1998-08-03 2009-12-02 大正製薬株式会社 フィルムコーティング錠剤

Also Published As

Publication number Publication date
ES2115188T3 (es) 1998-06-16
KR100319351B1 (ko) 2002-04-06
ATE164762T1 (de) 1998-04-15
US5472714A (en) 1995-12-05
SG44498A1 (en) 1997-12-19
AU678492B2 (en) 1997-05-29
JP3636380B2 (ja) 2005-04-06
ZA946874B (en) 1995-04-24
JPH07165584A (ja) 1995-06-27
IL110863A0 (en) 1994-11-28
AU7157194A (en) 1995-03-23
CA2131495C (fr) 2006-01-17
KR950007854A (ko) 1995-04-15
NZ264407A (en) 1995-12-21
EP0646374B1 (fr) 1998-04-08
DE59405627D1 (de) 1998-05-14
US5695782A (en) 1997-12-09
IL110863A (en) 1999-10-28
CA2131495A1 (fr) 1995-03-09
EP0646374A1 (fr) 1995-04-05

Similar Documents

Publication Publication Date Title
IL110863A0 (en) Double-layered oxcarbazepine tablets
ZA966320B (en) Corneal flap/cap elevator.
ZA964885B (en) Direct suture orifice for mechanical heart valve.
EP0615146A3 (fr) Disque à filtre chromatique monolithique.
EP0658044A3 (fr) Production d'images utilisant la diffusion d'erreur de couleur.
ZA9710379B (en) Modularly constructed lift.
CA2266444A1 (fr) Dihydrate d d'olanzapine
EP0584571A3 (fr) Compositions capables de changer de couleur.
AU8541098A (en) Pigment dispersions containing c.i. pigment red 222
EP1400523A3 (fr) Composés intermédiaires
EP0639526A3 (fr) Ascenseur de type tracté.
EP0650765A3 (fr) Aérographe à haute adaptabilité.
EP0823993A3 (fr) Microcapsules sensibles au PH.
EP0659843A3 (fr) Pigment non brillant.
EP0646631A3 (fr) Composition d'encre émettrice de lumière.
EP0640486A3 (fr) Imprimante couleur de type à transfert thermique.
ZA936552B (en) Color cosmetic composition.
EP0661215A4 (fr) Bouchon.
EP0600297A3 (fr) Machine à broder multicolore.
EP0628927A3 (fr) Marquage en forme de marques en couleur.
PH31578A (en) Peroxygene bleach composition.
PH30788A (en) Stabilized superoxide dismutase (sod) composition.
EP0682807A4 (fr) Amortissement du masque perfore pour les ecrans a tube cathodique couleur.
MD950171A (en) A Pharmaceutical remedy for impruving or remission - of excitement state during nervous deseases
EP0612728A3 (en) Anisomycin derivatives and anticancer agents, antifungal agents and antiprotozoan agents containing them.